The Strategic Marketplace Initiative (SMI) recently conducted a survey of their provider members to collect key information about the return to elective surgeries as they move into the recovery phase of the COVID-19 pandemic. SMI’s members are executives from providers and suppliers in the U.S., and they are on the front lines providing the critical supplies to help combat COVID-19.
90%
of the respondents answered they would be ready to resume elective cases in May/June, with 10% pushing that timeframe out to August.
100%
selected orthopedic surgery #1 of the top 5 specialties they would start first, with cardiothoracic surgery #2 at 90%, and general surgery #3 at 70%.
70%
said they would resume elective procedures in their ambulatory surgery center and their hospital simultaneously.
10%
anticipated resuming elective procedures in their ambulatory surgery center before starting procedures in the hospital.
75 to 100%
of hospitals who responded anticipate a gradual ramp-up in elective procedure volume, with volumes approaching or exceeding their pre-COVID-19 baseline by early 2021.
75%
of hospitals anticipate return to baseline capital expenditure in 12 to 24 months. Capital investment in equipment has taken a significant downturn during the COVID crisis and the ramp-up to full capital spending will be slow.
You can find the results in the SMI COVID-19 Toolkit at SMI: https://www.smisupplychain.com/tools
